SOPHiA GENETICS (SOPH) Total Non-Current Liabilities (2020 - 2026)

SOPHiA GENETICS has disclosed Total Non-Current Liabilities across 7 years of filings, most recently posting $64.2 million for Q2 2026.

• In Q2 2026, Total Non-Current Liabilities fell 3.44% year-over-year to $64.2 million; the TTM figure through Jun 2026 stood at $64.2 million (down 3.44% YoY), while the FY2025 annual figure was $65.4 million, up 104.14% from the prior year.
• Total Non-Current Liabilities came in at $64.2 million for Q2 2026 at SOPHiA GENETICS, down from $64.7 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $66.4 million in Q2 2025 to a low of $15.5 million in Q1 2022.
• Average Total Non-Current Liabilities over 5 years is $34.2 million, with a median of $25.5 million recorded in 2023.
• The largest YoY upside for Total Non-Current Liabilities was 125.7% in 2022 against a maximum downside of 4.65% in 2022.
• Over 5 years, Total Non-Current Liabilities stood at $16.9 million in 2022, then climbed by 12.99% to $19.1 million in 2023, then surged by 67.68% to $32.0 million in 2024, then jumped by 104.14% to $65.4 million in 2025, then retreated by 1.84% to $64.2 million in 2026.
• Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $64.2 million in Q2 2026, $64.7 million in Q1 2026, and $65.4 million in Q4 2025.